Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patients

Anvita Kale, Sadhana Joshi, Anilkumar R Pillai, Nilesh Naphade, MSVK S.V.K. Raju, Henry Nasrallah, Sahebarao P. Mahadik

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Impaired expression and function of several major neurotrophic factors such as nerve growth factor (NGF) has been proposed to contribute to the neurodevelopmental pathology of schizophrenia. However, the evidence in the majority of studies is based on variable and inconsistent levels of plasma NGF in diverse populations of early psychosis or medicated patients with chronic schizophrenia. We report here the first study comparing NGF levels in cerebrospinal fluid (CSF) and plasma from a unique patient cohort (unmedicated, early psychotic patients with similar racial and dietary patterns) and matched healthy controls. Significantly lower levels of NGF in both CSF (p = 0.038) and plasma (p = 0.002) were observed in drug-naïve first-episode psychosis patients as compared to controls. The levels of NGF in the CSF correlated (p = 0.05) to the plasma values in controls. The data on plasma NGF confirm the reported deficits of NGF in drug-naïve first-episode psychosis. The reduced levels first time observed here may have important implications to repeatedly reported neurobiological and clinical deficits which are discussed.

Original languageEnglish (US)
Pages (from-to)209-214
Number of pages6
JournalSchizophrenia Research
Volume115
Issue number2-3
DOIs
StatePublished - Dec 1 2009

Fingerprint

Nerve Growth Factor
Cerebrospinal Fluid
Pharmaceutical Preparations
Psychotic Disorders
Schizophrenia
Nerve Growth Factors
Pathology
Population

Keywords

  • Cerebrospinal fluid
  • Nerve growth factor
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Kale, A., Joshi, S., Pillai, A. R., Naphade, N., Raju, MSVK. S. V. K., Nasrallah, H., & Mahadik, S. P. (2009). Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patients. Schizophrenia Research, 115(2-3), 209-214. https://doi.org/10.1016/j.schres.2009.07.022

Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patients. / Kale, Anvita; Joshi, Sadhana; Pillai, Anilkumar R; Naphade, Nilesh; Raju, MSVK S.V.K.; Nasrallah, Henry; Mahadik, Sahebarao P.

In: Schizophrenia Research, Vol. 115, No. 2-3, 01.12.2009, p. 209-214.

Research output: Contribution to journalArticle

Kale, A, Joshi, S, Pillai, AR, Naphade, N, Raju, MSVKSVK, Nasrallah, H & Mahadik, SP 2009, 'Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patients', Schizophrenia Research, vol. 115, no. 2-3, pp. 209-214. https://doi.org/10.1016/j.schres.2009.07.022
Kale, Anvita ; Joshi, Sadhana ; Pillai, Anilkumar R ; Naphade, Nilesh ; Raju, MSVK S.V.K. ; Nasrallah, Henry ; Mahadik, Sahebarao P. / Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patients. In: Schizophrenia Research. 2009 ; Vol. 115, No. 2-3. pp. 209-214.
@article{9a76fd893d004e88ab01112cf0a2b9f4,
title = "Reduced cerebrospinal fluid and plasma nerve growth factor in drug-na{\"i}ve psychotic patients",
abstract = "Impaired expression and function of several major neurotrophic factors such as nerve growth factor (NGF) has been proposed to contribute to the neurodevelopmental pathology of schizophrenia. However, the evidence in the majority of studies is based on variable and inconsistent levels of plasma NGF in diverse populations of early psychosis or medicated patients with chronic schizophrenia. We report here the first study comparing NGF levels in cerebrospinal fluid (CSF) and plasma from a unique patient cohort (unmedicated, early psychotic patients with similar racial and dietary patterns) and matched healthy controls. Significantly lower levels of NGF in both CSF (p = 0.038) and plasma (p = 0.002) were observed in drug-na{\"i}ve first-episode psychosis patients as compared to controls. The levels of NGF in the CSF correlated (p = 0.05) to the plasma values in controls. The data on plasma NGF confirm the reported deficits of NGF in drug-na{\"i}ve first-episode psychosis. The reduced levels first time observed here may have important implications to repeatedly reported neurobiological and clinical deficits which are discussed.",
keywords = "Cerebrospinal fluid, Nerve growth factor, Schizophrenia",
author = "Anvita Kale and Sadhana Joshi and Pillai, {Anilkumar R} and Nilesh Naphade and Raju, {MSVK S.V.K.} and Henry Nasrallah and Mahadik, {Sahebarao P.}",
year = "2009",
month = "12",
day = "1",
doi = "10.1016/j.schres.2009.07.022",
language = "English (US)",
volume = "115",
pages = "209--214",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patients

AU - Kale, Anvita

AU - Joshi, Sadhana

AU - Pillai, Anilkumar R

AU - Naphade, Nilesh

AU - Raju, MSVK S.V.K.

AU - Nasrallah, Henry

AU - Mahadik, Sahebarao P.

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Impaired expression and function of several major neurotrophic factors such as nerve growth factor (NGF) has been proposed to contribute to the neurodevelopmental pathology of schizophrenia. However, the evidence in the majority of studies is based on variable and inconsistent levels of plasma NGF in diverse populations of early psychosis or medicated patients with chronic schizophrenia. We report here the first study comparing NGF levels in cerebrospinal fluid (CSF) and plasma from a unique patient cohort (unmedicated, early psychotic patients with similar racial and dietary patterns) and matched healthy controls. Significantly lower levels of NGF in both CSF (p = 0.038) and plasma (p = 0.002) were observed in drug-naïve first-episode psychosis patients as compared to controls. The levels of NGF in the CSF correlated (p = 0.05) to the plasma values in controls. The data on plasma NGF confirm the reported deficits of NGF in drug-naïve first-episode psychosis. The reduced levels first time observed here may have important implications to repeatedly reported neurobiological and clinical deficits which are discussed.

AB - Impaired expression and function of several major neurotrophic factors such as nerve growth factor (NGF) has been proposed to contribute to the neurodevelopmental pathology of schizophrenia. However, the evidence in the majority of studies is based on variable and inconsistent levels of plasma NGF in diverse populations of early psychosis or medicated patients with chronic schizophrenia. We report here the first study comparing NGF levels in cerebrospinal fluid (CSF) and plasma from a unique patient cohort (unmedicated, early psychotic patients with similar racial and dietary patterns) and matched healthy controls. Significantly lower levels of NGF in both CSF (p = 0.038) and plasma (p = 0.002) were observed in drug-naïve first-episode psychosis patients as compared to controls. The levels of NGF in the CSF correlated (p = 0.05) to the plasma values in controls. The data on plasma NGF confirm the reported deficits of NGF in drug-naïve first-episode psychosis. The reduced levels first time observed here may have important implications to repeatedly reported neurobiological and clinical deficits which are discussed.

KW - Cerebrospinal fluid

KW - Nerve growth factor

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=71949130852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71949130852&partnerID=8YFLogxK

U2 - 10.1016/j.schres.2009.07.022

DO - 10.1016/j.schres.2009.07.022

M3 - Article

C2 - 19713082

AN - SCOPUS:71949130852

VL - 115

SP - 209

EP - 214

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 2-3

ER -